Skip to main content
. Author manuscript; available in PMC: 2019 Nov 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2018 Jun 13;102(4):821–829. doi: 10.1016/j.ijrobp.2018.06.003

Table 1:

Summary of HRS analysis in BlaStM patients

Patients Prostate Volume (cc) Mean No. habitats/Pt Habitat Volume/Pt (mean ± SD cc) Habitat Volume/lesion (mean ± SD cc) PZ N (%) TZ N (%) Both N (%)
Total (n = 37) 39.6 1.38 3.6 ± 3.74 2.83 ± 3.34 16 (43.2) 10 (27.1) 11 (29.7)
Intermediate risk (n = 21) 42.1 1.48 3.37 ± 3.93 2.67 ± 3.34 9 (42.9) 4 (19.0) 8 (38.1)
High risk (n = 16) 36.2 1.25 3.91 ± 3.68 3.76 ± 3.22 7 (43.8) 6 (37.5) 3 (18.7)

Abbreviations: PZ = Peripheral Zone; TZ = Transition Zone